Complexa Inc News Today

-  Appointment of Elisabeth Leiderman, M.D. -  Resignation of Kapil Dhingra, M.D. LONDON, Dec. 22, 2023 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing...

Pathalys Pharma Announces Executive Team Appointments - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- Pathalys Pharma, Inc., a private, late-stage biopharma company committed to the development and commercialization of a range of best-in-class...

Glomerulonephritis Treatment Market by drug class (Corticosteroids, Diuretic, Alkylating Agents) and by distribution channel (Hospital Pharmacies, E-commer

Glomerulonephritis Treatment Market by drug class (Corticosteroids, Diuretic, Alkylating Agents) and by distribution channel (Hospital Pharmacies, E-commer

Marketing Strategy comprehension, Distributors and Traders Study on Market Research Factors Global Blood Pressure Disorders Drug Market Forecast Chapter 1: Blood Pressure Disorders Drug Market Overview Chapter 2: Economic Impact on Industry Chapter 3: Market Competition by Manufacturers Chapter 4: Production, Revenue (Value) by Region Chapter 5: Supply (Production), Consumption, Export, Import by Regions Chapter 6: Production, Revenue (Value), Price Trend by Type Chapter 7: Market Analysis by A...

Published: Dec 18, 2020 By Alex Keown Cidara Therapeutics – Christopher Kurtz was named executive vice president of Technical Operations at Cidara Therapeutics. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. He previously served as vice presiden...